<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82928">
  <stage>Registered</stage>
  <submitdate>24/06/2008</submitdate>
  <approvaldate>26/06/2008</approvaldate>
  <actrnumber>ACTRN12608000306314</actrnumber>
  <trial_identification>
    <studytitle>Acute effect of resistance exercise on blood glucose levels in Type 1 diabetes</studytitle>
    <scientifictitle>Acute effect of resistance exercise on blood glucose levels in Type 1 diabetes</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Type 1 diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Blood glucose is measured continuously during two 3-day periods. During one of these 3-day periods, a 1 hour resistance exercise session is performed consisting of the following exercises: Bench Press, Leg Extensions, Upright Row, Lateral Pull-downs, Dumbbell Flys, squats and abdominal crunches. During the other 3-day period no exercise is performed. Each participant acts as their own control and completes both 3-day periods with a minimum of 3 days washout in between.</interventions>
    <comparator>No exercise.</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Blood glucose (measured continuously)</outcome>
      <timepoint>Baseline (pre-exercise/control), Day 1 (Exercise/Control session and following evening), Day 1 overnight, Day 2, Day 2 overnight, and Day 3.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety - post resistance exercise hypoglycemia. Hypoglycemic will be assesses by examining blood glucose levels following resistance exercise compared to rest. This will be measured from the continuous glucose monitor downloaded data.</outcome>
      <timepoint>Total time spent with blood glucose level below 3.5mmol/l in the 48 hours following resistance exercise compared to rest.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Type 1 diabetes</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>History of hypoglycemic unawareness, untreated proliferative retinopathy, proteinuria, cardiovascular disease, any absolute exercise contraindications.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>A Treatment session (1-hour resistance exercise) and control (no exercise) is conducted by each participant during the two 3-day periods in random order. Order determined for each partciipant by random selection of sealed envelope containing order.</concealment>
    <sequence>Total of 16 envelopes - half sealed envelopes contained exercie/rest and half contained rest/exercise.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>3/03/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Novo Nordisk Regional Diabetes Support Scheme</primarysponsorname>
    <primarysponsoraddress>PO Box 863, Hawthorn, VIC 3122</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Novo Nordisk Regional Diabetes Support Scheme</fundingname>
      <fundingaddress>PO Box 862, Hawthorn, VIC 3122</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Medtronic Minimed</fundingname>
      <fundingaddress>Northridge, California</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other</sponsortype>
      <sponsorname>International Diabetes Institute</sponsorname>
      <sponsoraddress>250 Kooyong Road, Caulfield, VIC 3162</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Beneficial effects of moderate- to high- injtensity resistance exercise have been reported in Type 2 diabetes but there is little information available regarding the effects of resistance exercise in Type 1 diabetes. Therefore the purpose of this study is to examine the effects of an acute bout of moderate- to high- intensity resistance exercise on 48-hour blood glucose profiles in Type 1 diabetes using continuous glucose monitoring.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>International Diabetes Institute Ethics Committee</ethicname>
      <ethicaddress>c/- 250 Kooyong Road, Caulfield, VIC 3162</ethicaddress>
      <ethicapprovaldate>22/01/2005</ethicapprovaldate>
      <hrec>7/2004</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Carol Robinson</name>
      <address>International Diabetes Institute
250 Kooyong Road, Caulfield, VIC 3162</address>
      <phone>(03) 9258 5075</phone>
      <fax>(03) 9258 5090</fax>
      <email>crobinson@idi.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Carol Robinson</name>
      <address>International Diabetes Institute
250 Kooyong Road, Caulfield, VIC 3162</address>
      <phone>(03) 9258 5075</phone>
      <fax>(03) 9258 5090</fax>
      <email>crobinson@idi.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Carol Robinson</name>
      <address>International Diabetes Institute
250 Kooyong Road, Caulfield, VIC 3162</address>
      <phone>(03) 9258 5075</phone>
      <fax>(03) 9258 5090</fax>
      <email>crobinson@idi.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>